QuickView for sorbitol metabolic process (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
3. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
4. L1000 CMAP Lung cancer NCI-H1299 cells with gene overexpression perturbations
5. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations

There were no matches for sorbitol metabolic process

1. Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SOR…
2. A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudi…
3. Acid-Base Balance, Metabolism and Minerals
4. Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients
5. Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Ma…